Français Japonais Chinois Allemand Néerlandais Espagnol Portugais

    News

    Success story: Amaris Lille set to expand

    Switzerland-based Amaris opened an office in Hauts-de-France in late 2015. Ranked among Europe’s leading independent consulting groups, the company is growing exponentially.

    Lille shortlisted as World Design Capital 2020

    Greater Lille and Sydney are the finalists for the biennial title, awarded by the World Design Organization.

    All news

    New biopharma start-up at Lille's Institut Pasteur

    10 Aug 2016 | Health Nutrition, A region on the move

    A revolutionary start-up has just seen the light of day at the Institut Pasteur campus in Lille. Immune InsighT is a biotech business specialized in analyses to confirm new drug candidates are safe. The company harnesses rare expertise to offer a unique services to clients around the world.

    Immune InsighT at Lille's Institut Pasteur

    Lille's Institut Pasteur is an international pace-setter and a key player in medical research. Over the past fifteen years, a dozen start-ups have been set up on its campus or through its research teams—including Immune InsighT in 2016.

    Immune InsighT offers an all-new, high-end method for confirming the safety of new drug candidates designed to treat cancer, transplants, auto-immune system and inflammatory illnesses, and applications in agrifood and the cosmetic industry prior to the launch of clinical tests. This fast-moving young company offers unique services worldwide.

    Completing the full range of tests offered by Immune InsighT early on enables client companies to identify the undesirable effects of drug candidates or other molecules on the immune system both reliably and quickly—and to anticipate the potential failure of a long and costly clinical trial well in advance. 

     

    Source: Lille's Institut Pasteur

    Back to news